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ABSTRACT  Mechanisms of Ca  2+ sensitization of both myosin light chain (MLC) 
phosphorylation and force development by protein kinase C (PKC) were studied in 
permeabilized  tonic smooth muscle obtained  from the  rabbit  femoral artery.  For 
comparison,  the  Ca  2+  sensitizing  effect  of  guanosine  5'-O-(v-thiotriphosphate) 
(GTP~/S) was examined, which had been previously shown to inhibit MLC phospha- 
tase in phasic vascular smooth muscle. We now report that PKC activators (phorbol 
esters,  short  chain  synthetic  diacylglycerols and  a  diacylglycerol kinase  inhibitor) 
and  GTP~/S  significantly  increase  both  MLC  phosphorylation  and  force develop- 
ment at constant  [Ca2+].  Major phosphorylation site occurring in the presence  of 
phorbol-12,13-dibutyrate  (PDBu)  or GTP~S at constant  [Ca  ~+]  is  the  same  serine 
residue  (Ser-19)  as  that  phosphorylated by MLC  kinase  in  response  to increased 
Ca  ~+  concentrations.  In  an  ATP-  and  Ca2+-free  solution  containing  1-(5-chloro- 
naphthalene-l-sulfonyl)-lH-hexahydro-l,4-diazepine  (ML-9),  to  avoid  the  kinase 
activity, both  PDBu and  GTP~/S  significantly decreased  the  rate  of MLC dephos- 
phorylation to half its control value.  However, PDBu inhibited  the relaxation  rate 
more than did GTP~/S. In the presence of microcystin-LR to inhibit the phosphatase 
activity, neither PDBu nor GTP~/S  affected MLC phosphorylation and force devel- 
opment.  These  results  indicate  that  PKC,  like activation of GTP binding protein, 
increases  Ca  2+  sensitivity  of both  MLC  phosphorylation  and  force  production 
through inhibition of MLC phosphatase. 
INTRODUCTION 
In  smooth  muscle,  phosphorylation  of  the  20,000  D  myosin  light  chain  (MLC) 
leading  to  contraction  is  primarily  regulated  by cytoplasmic  Ca 2+.  A  rise  in  Ca ~+ 
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increases  the  MLC  kinase/phosphatase  activity  ratio  by  activation  of the  kinase 
(reviewed  in  Hartshorne,  1987,  and  Kamm  and  Stull,  1989).  However, the  Ca  ~+ 
sensitivity  of MLC phosphorylation and force development is strongly modulated by 
physiological regulatory mechanisms (Morgan and Morgan,  1984; also see Kitazawa, 
Gaylinn,  Denney, and  Somlyo,  1991a,  for references).  In  addition  to Ca  2+  release 
from the sarcoplasmic reticulum, cx]-adrenergic  (Kitazawa  et al.,  1991a) and musca- 
rinic agonists (KJtazawa and Somlyo, 1990) can increase both MLC phosphorylation 
and force at constant Ca  2+ in Staphylococcus  aureus a-toxin-permeabilized vascular and 
intestinal smooth muscle, respectively. These increases in MLC phosphorylation and 
force by agonists are mimicked by GTP~/S and inhibited by GDPI3S, indicating that G 
protein(s)  couple  excitatory  receptors  to  a  Ca~+-sensitizing  system  (Nishimura, 
Kobler,  and  van  Breemen,  1988;  Fujiwara,  Itoh,  Kubota,  and  Kuriyama,  1989; 
Kitazawa,  Kobayashi, Horiuti, Somlyo, and Somlyo, 1989). Recent studies on perme- 
abilized phasic vascular smooth muscle further demonstrated that this Ca2+-sensitiz - 
ing action of agonist and GTP~tS was mediated through inhibition of MLC phospha- 
tase, thereby increasing the MLC kinase/phosphatase activity ratio (Kitazawa, Masuo, 
and  Somlyo,  1991b).  Similar  inhibition  of MLC  phosphatase  by GTP~/S was  also 
shown in tracheal homogenates (Kubota, Nomura, Kamm, Mumby, and Stull,  1992). 
The molecular mechanisms of signal transduction between G protein activation and 
phosphatase inhibition,  however, remain to be identified. 
G  protein-coupled  activation  of phospholipase  C  results  in  production  of two 
distinct  transmitters,  inositol  -1,4,5-trisphophate  and  diacylglycerol  (DAG)  from 
phosphatidylinositol  4,5-bisphosphate  (Berridge,  1987;  Nishizuka,  1984).  The 
former  transmitter  acts as a  second messenger  for fast  (less  than  a  second)  Ca  2+ 
release from the sarcoplasmic reticulum of smooth muscle, but by itself has no effect 
on Ca  2+ sensitivity  (Kitazawa and Somlyo, 1991). Therefore, the hypothesis that DAG 
activating  PKC  acts  as  a  second  messenger  for  the  slow  (several  seconds)  Ca  2+ 
sensitization  of the  regulatory/contractile  apparatus,  seems attractive  (Rasmussen, 
Takuwa,  and  Park,  1987; Jiang  and  Morgan,  1987;  Nishimura  and van  Breemen, 
1989). In fact, phorbol ester, a direct activator of PKC, initiates slowly developing and 
sustained  contractions  (Rasmussen,  Forder,  Kojima,  and  Scriabine,  1984;  Itoh, 
Kabota, and  Kuriyama,  1988;  Rembold and  Murphy,  1988;  Ruzycky and  Morgan, 
1989; Ozaki, Ohyama, Sato, and Karaki,  1990; Singer,  1990a),  but their relationship 
to intracellular Ca  2+ concentration in intact smooth muscles is controversial. Phorbol 
esters likewise increase the contractile Ca  2+ sensitivity  of permeabilized preparations 
(Chatterjee and Tejada,  1986;  Itoh,  Kubota, and Kuriyama,  1988;  Miller,  Hawkins, 
and Wells,  1986;  Fujiwara,  Itoh,  Kubota, and  Kuriyama,  1988;  Nishimura  and van 
Breemen,  1989).  PKC phosphorylates MLC at Ser-1  and -2 and Thr-9 distinct from 
MLC  kinase  sites  (Ser-19  and  Thr-18)  (Ikebe,  Hartshorne,  and  Elzinga,  1987a; 
Bengur,  Robinson, Apella,  and  Sellers,  1987).  Phosphorylation  of PKC-sites,  how- 
ever, inhibits or has no effect on either actin-activated  myosin ATPase (Nishikawa, 
Hidaka,  and  Adelstein,  1983;  Bengur  et  al.,  1987;  Ikebe  et  al.,  1987a)  or  on 
contraction  of glycerol-permeabilized smooth  muscle  strips  (Sutton  and  Haeberle, 
1990). Recent quantitative measurements also have revealed that agonist stimulation 
induces phosphorylation of MLC at MLC kinase-specific, but not at PKC-specific  sites 
(Singer,  Oren,  and  Benscoter,  1989;  Kamm,  Hsu, Kubota,  and  Stull,  1989).  These MASUO ZT AL.  Ca  2+ Sensitization  by Protein Kinase C  267 
observations  strongly suggest  that  additional  mechanism(s)  other than  direct phos- 
phorylation of MLC by PKC must be operative in situ through which PKC activators 
can increase the sensitivity of the regulatory/contractile apparatus to Ca  ~+. 
The  purpose  of the  present  study was  (a)  to examine  whether  a  variety  of PKC 
activators  can  increase  both  MLC  phosphorylation  and  force  at  a  given  Ca  ~+ 
concentration  as  has  been  seen  with  GTP~/S  and  agonists  in  Staphylococcus  aureus 
(~-toxin  permeabilized  smooth  muscle  (Kitazawa  et  al.,  1991a);  and,  if  so,  (b)  to 
identify using  phosphopeptide  analysis, whether  MLC kinase  or PKC mainly phos- 
phorylates  MLC during  the  Ca  2+  sensitization  by PKC activation;  and  (c)  to deter- 
mine whether the mechanism involved in Ca  2+ sensitization of MLC phosphorylation 
by PKC activation is inhibition of MLC dephosphorylation (in a manner similar to the 
action of GTP~/S and agonists),  or activation of MLC phosphorylation (analogous to 
the  action  of Ca2+),  or both.  We  now  document  a  novel  mechanism  for the  Ca  ~+ 
sensitizing action of PKC through inhibition of MLC dephosphorylation in the signal 
transduction systems. A preliminary report of some of these findings has been already 
presented  (Kitazawa,  Reardon,  Ikebe, and Masuo,  1993). 
MATERIALS  AND  METHODS 
Methods 
Tissue preparation  and force measurement. The femoral arteries were dissected from male albino 
rabbits  (2-3  kg).  The  arterial  strips  were  carefully  freed  from connective  tissue  and  their 
endothelium was removed by rubbing with a razor blade. The smooth muscle strips 50-60 ~m 
thick, 500-600 ~m wide and 2.5-3 mm long were used for measurements of both force and 
phosphorylation.  The  strips  were  then  tied with  silk  monofilament  to  the  fine  tips  of two 
tungsten  needles,  one  of which  was  connected  to  a  force  transducer  (AMS01,  SensoNor, 
Horten,  Norway),  and  mounted  in  a  well  on  bubble  plate  (Horiuti,  1988)  to  allow  either 
moderately rapid (within a second) solution exchange or freezing, as described (Kitazawa et al., 
1991a).  All experiments were carried out at 20~ 
Solutions. The normal relaxing solution contained (in millimolar): potassium methanesul- 
fonate, 74.1; Mg  2+, 2; MgATP, 4.5; EGTA,  1; creatine phosphate,  10; piperazine-N,N'-bis(2- 
ethanesulfonic acid), 30, neutralized to pH 7.1 with KOH at 20~  In the activating solution, 10 
mM EGTA was used and a specified amount of calcium methanesulfonate was added to give a 
desired concentration of free Ca  2+ ions (Horiuti,  1988). Ionic strength was kept constant at 0.2 
M by adjusting the concentration of potassium methanesulfonate. 
Cell permeabilizations. We used three distinct cell-permeabilization techniques depending 
on the purpose of each experiment; a-toxin, 13-escin, and saponin, oL-toxin produces 2-3-nm 
diam pores in the plasma membrane that permit  the passage of only low molecular weight 
solutes (e.g.,  Ca  2+, ATP, GTP, InsP3, phorbol esters),  so that soluble cytosolic proteins such as 
calmodulin, kinases and phosphatases are retained in the cell at their physiological concentra- 
tions  (Kitazawa  et  al.,  1989).  Because  receptor/G  protein-coupled  as well  as  Ca2+-activated 
responses are well preserved (Kitazawa et al.,  1989), most of the studies were performed using 
this preparation.  Microcystin-LR (M~ = 995) applied to the extracellular space to inhibit MLC 
phosphatase, however, does not readily penetrate into c~-toxin permeabilized cells.  I$-escin, on 
the other hand, can make cell membranes permeable to much higher molecular weight solutes 
such  as  microcystin-LR and  calmodulin.  These  13-escin-permeabilized  smooth  muscles  also 
retain  coupled  receptors  (Kobayashi,  Kitizawa,  Somlyo,  and  Somlyo,  1989).  However,  the 
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tions.  Finally,  to  examine  the  direct  effects  of  guanine  nuclcotides  and  drugs  on  the 
regulatory/contractile apparatus  of smooth  muscle, we  used  receptor/G  protein-uncoupled 
preparations permcabilized with high concentrations of saponin (Kitazawa et al.,  1991b). 
After measuring contractions induced by high K  + (154 raM) and by phenylephrine (100 p,M), 
the strips wcrc incubated at room temperature (20-23~  in the relaxing solution for several 
minutes. For permeabilization with a-toxin, the strips were treated for 25--35 min with 5,000 
U/ml of purified Staphylococcus  aureus a-toxin at pCa 6.7, buffered with l0 mM EGTA, at 30~ 
To maintain cytoplasmic Ca  2+ constant, the sarcoplasmic reticulum was depleted of calcium by 
further treating each strip with l0 p.M A23187, a Ca2+-ionophore for 20-25 rain in the relaxing 
solution. 
To determine the time course of MLC phosphorylation in the presence of microcystin-LR, 
smooth  muscle strips wcrc  incubated in normal relaxing solution for  several minutes and 
treated for 45 min with 40 p,M 13-escin  at 5~  The temperature was subsequently increased to 
30~  and 10 p,M A23187 was added. Permeabilization  was continued for a total of 60 min. The 
initial treatment with  13-escin at  a  low  temperature  did  not  significantly permeabilize the 
membrane, but it was required to obtain subsequent homogeneous permeabilization  at a higher 
temperature (30~  over a short period, suggesting slow penetration and/or binding of 13-escin 
to the surface membrane of the strips. 
In some experiments, muscles were extensively permeabilized with 200  p,g/ml saponin at 
25~  for 20 min in relaxing solution to which was added 10 }~M A23187, 1 p.M calmodulin, 100 
p.M leupeptin and 5 mM dithiothreitol. 
Two-dimensional gel electrophoresis.  For measuring MLC  phosphorylation, permeabilizcd 
preparations were  rapidly  frozen with  liquid  N~-cooled  chlorodifluorumethane (Freon  22; 
Atochem,  Philadelphia,  PA)  at  intervals  indicated  in  the  figures.  Force  was  monitored 
throughout the experiment. MLC was separated by two-dimensional isoclectric  focusing/SDS 
gcl electrophorcsis and stained with colloidal gold (Kitazawa ct al.,  1991a). The percentage of 
MLC phosphorylation was calculated by dividing the density of the mono- and diphosphory- 
lated spots by the combined density ofun-, mono-, and diphosphorylated spots. The amount of 
the di-phosphorylated smooth muscle MLC was compensated by subtracting the average value 
(5.6% of the total MLC) of unphosphorylated nonmuscle MLC that comigrated with diphos- 
phorylated smooth muscle MLC (Kitazawa et al.,  1991a). 
Phosphopeptide  analysis.  Arterial smooth muscle strips permeabilized with a-toxin were 
incubated in the ATP-free, 10 mM EGTA-containing  solution at 25~  for 30 rain. After washing 
with  additional  EGTA-  and  ATP-free  solution,  the  strips  were  incubated  in  a  solution 
containing 4  mM [,/-3~P]ATP and the appropriate Ca  ~+  concentration buffered with  10 mM 
EGTA in the presence of 4 ~M PDBu or 100 p~M GTP~S or in the absence of both for 15 min 
at 20~  The specific radioactivity of [~/_32p] ATP was 106 cpm/nmol. The reaction was stopped 
by the addition of trichloroacetic acid to a 5% final concentration. The muscle strips were then 
dissolved in a  solution containing 4% SDS, 0.5  M NaHCOs and  1%  [3-mercaptoethanol and 
subjected  to  SDS-polyacrylamide gel  electrophoresis.  The  gel  was  in  contact with  Kodak 
X-Omat film overnight and the 20,000 D MLC band was excised from the gel. 
The excised gel was cut into small pieces which were washed three times with 25% propanol 
and then three additional times with 10% methanol. The gels were lyophilized and rehydrated 
with 9 M urea solution containing  50 mM Tris-HCl (pH 8.0) and incubated at 37~  for 1 h. The 
urea  concentration was  decreased  to  2  M  with  H20  and  0.1  mg/ml of L-l-tosylamido-2- 
phenylethyl chloromethyl ketone (TPCK)-treated trypsin (Sigma Chemical Co., St. Louis,  MO) 
was added. After 3 h, an additional 0.1 mg/ml of TPCK-trypsin  was added and the mixture was 
incubated for  ~ 12 h at 37~  The gel was removed and the extracted peptide mixture had its 
pH adjusted to 2.2 and was then subjected to C18 reverse-phase HPLC column chromatogra- 
phy (Brownlee Spheri50DS column). The peptides were eluted using a linear gradient to 5% MASUO ET AL.  Ca  2+ Sensitization by Protein Kinase C  269 
CHsCN at 30 min and to 100% CHsCN at 60 min in the presence of 0.1% trifluoroacetk acid at 
a  flow rate of 0.8  ml/min. The radioactivity  of each fraction was monitored by a  Beckman 
LS5000  scintillation  counter using Cerenkov counting. The recovery of s2p-labeled  pepddes 
from the gel slices ranged between 30-50%. 
Phospho-amino acid analysis was done according to the methods of Ikebe and Hartshorne 
(1985). 
As a control, isolated MLC was phosphorylated either by MLC kinase or PKC and treated as 
described  above.  MLC  kinase was  prepared from turkey gizzard  (Ikebe, Stepinska,  Kemp, 
Means,  and Hartshorne,  1987b) and PKC from bovine brain (Ikebe and Reardon,  1990). 
Statistical significance was evaluated by an unpaired two-tailed t test. A value ofP <  0.05 was 
taken as significant. All values are expressed in mean -+ SE for 4-12 experiments. 
Chemicals 
a-toxin, PDBu, 40t- and 4fl-PDBu,  and 4a- and 4[5-PMA were from Gibco BRL (Gaithersburg, 
MD); 13-escin, microcystin-LR,  diC6, diCs,  1,3-diC8 and bexokinase from Sigma Chemical Co.; 
DAG  kinase  inhibitor  (R59022),  GTP~tS, and  GDP[~S from  Boehringer  Mannheim  Corp. 
(Indianapolis,  IN);  ML-9 and  A23187  from Caibiochem Corp.  (San  Diego,  CA). All  other 
chemicals were of reagent grade purity. 
RESULTS 
The Effect of Phorbol Ester on  Contraction  in Intact Rabbit Femoral Artery 
Smooth Muscle 
To compare the phorbol ester-induced responses of our preparations with previous 
reports,  we  performed  measurements  of  contractile  responses  on  intact  rabbit 
femoral  artery  smooth  muscle  strips.  Under  resting  conditions,  0.3  v.M  PDBu 
produced  a  contraction  equal to 49  -+  12% of al-agonist (100  v.M phenylephrine)- 
induced contraction with a half time (time required to reach 50% of maximum force 
induced by the given stimulant) of 5.0  +-- 0.7 min. Stimulation by high (154 raM) K + 
induced  a  phasic contraction which  developed rapidly and returned  to a  sustained 
lower level (24 --+ 8% of phenylephrine-induced  contraction)  after peak.  During the 
sustained  contractions  induced  by  high  K §  PDBu  more  rapidly  (half-time  of 
2.9 --- 0.1  min)  evoked  a  larger  contraction  (106 --- 6%  of phenylephrine-induced 
contraction)  than  those  evoked by PDBu  in  resting  state.  In  the  absence of Ca  ~§ 
PDBu-induced  contractions  were  significantly  smaller  (28 -+ 5%  of phenylephrine- 
induced contraction in the presence of Ca  2+) and slower (6.3 --- 0.3 min) even in high 
K + solutions than those occurring in the presence of Ca  2+. These results suggest that 
the rapidity and amplitude of phorbol ester-induced contractions in unpermeabilized 
smooth muscle are dependent upon the level of cytoplasmic Ca  2+. 
The Ca2+-sensitizing Effect of Various PKC Activators  on  Contraction  in  a-Toxin 
Permeabilized Arterial  Smooth Muscle 
Fig.  1 A  shows  a  representative  tracing  of  the  G  protein-dependent  contractile 
response of s-toxin permeabilized, A23187-treated femoral artery smooth muscle. An 
ctl-agonist  (100  ~M  phenylephrine)  in  the  presence  of  10  ~M  GTP  moderately 
enhanced contractile response in the presence of submaximal Ca  2+ (pCa 7 buffered 
with  10 mM  EGTA). GDP~S (1  raM)  reversibly inhibited  agonist-induced  enhance- 270  THE JOURNAL OF GENERAL PHYSIOLOGY ￿9  VOLUME 104 ￿9  1994 
ment  of contraction  at  constant  Ca  2+,  indicating  G  protein-mediated  regulation  of 
Ca  2+  sensitivity  of  arterial  smooth  muscle  contraction,  as  previously  described 
(Kitazawa et al.,  1989,  1991a). At pCa 7, a  saturating concentration of nonhydrolyz- 
able GTP analog, GTP~/S (100  p,M) increased the contractile force from 4  _+ 0.9% to 
64  -  1.8% of the maximum force obtained at pCa 5. 
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FIGURE  1.  Potentiating effect of various PKC activators on contraction activated by submaxi- 
mal Ca  2+ in ~x-toxin-permeabilized  rabbit femoral artery smooth muscle in comparison with 
those of agonist and GTP~/S. Ca  2+ release from intracellular stores was eliminated by treatment 
of permeabilized smooth muscle with 10 p.M A23187. The muscles were incubated in Ca2+-free 
(pCa >  8),  1 mM EGTA-containing solution, followed by increase in Ca  2+ to pCa 7 and 5 with 
10 mM  EGTA-containing solutions.  (A)  100  p,M Ctl-agonist,  phenylephrine  (PE)-potentiated 
contraction at constant Ca  2+ (pCa 7) was inhibited by 1 mM GDP[3S. All solutions contained 10 
p,M  GTP.  The  nonhydrolyzable GTP analog,  GTP~/S evoked much larger  contraction  than 
agonists, pCa 5 evoked maximal contraction that was not affected by GTP~S and PDBu. (B) 
Potentiation of contraction at constant Ca  2+ by 3 p,M PDBu, but not by even 100 IxM 4ct-PDBu, 
an inactive isomer. (C and D) Potentiation of contraction by 10 p,M diC6 at pCa 7 (C) and 50 
~M DAG kinase inhibitor, R59022 at pCa 6.7 (D). 
The  effects  of different  classes  of PKC  activators  were  next  examined  in  these 
preparations.  These included two classes of direct activators:  (a) phorbol esters  such 
as  413-phorbol  12,13-dibutyrate  (PDBu)and  4[~-phorbol  12-myristate  13-acetate 
(PMA); and (b) synthetic short chain  1,2-sn-diacylglycerols such as  1,2-sn-dihexanoyl- 
glycerol  (diC6)  and  1,2-sn-dioctanoylglycerol  (diCs)  (Lapetina,  Reep,  Ganong,  and MASUO ET AL.  Ca  2+ Sensitization  by Protein Kinase C  271 
Bell,  1985).  In addition,  R59022,  an inhibitor of DAG kinase which can inhibit the 
metabolism of 1,2-DAG to phosphatidic acid so as to lead to an accumulation of DAG 
(de Chaffoy de Courcelles, Re,  evens, and Van Belle,  1985), was examined. 
As shown in Fig.  1 B, PDBu was capable of markedly enhancing the contraction of 
a-toxin permeabilized femoral artery smooth muscle under Ca2+-clamped conditions 
(pCa  7)  at  20~  in  a  manner  similar  to  that  produced  by GTP'yS (Fig.  1 A).  The 
maximum stimulation of force development by PDBu (from 2  --- 0.4% to 61  -+ 0.9% 
of maximum force obtained at pCa 5) was seen at a  level of 0.1  ~M, and increasing 
the concentrations of this activator to between 0.3 and 3 ttM had no further increase 
in amplitude. The ECs0  of PDBu on amplitude of contraction at pCa 7 was  10 nM. 
The half-time of force development by PDBu even at concentrations ranging between 
0.1  and 3 I~M was, however, dose-dependently decreased;  10.9 -+ 0.6 rain at 0.1  I~M, 
6.2  -  0.4 rain at 0.3 ttM and 4.1  +  0.1  rain at 3 ~M. An increase in Ca  2+ to pCa 6.5 
significantly decreased the half-time of 0.3  IxM PDBu-induced  force development to 
2.5  +  0.4  rain.  PMA,  on  the  other  hand,  was  found  to  induce  only  very  slow 
potentiation  of  the  contractile  force  (half  time  of  1.5  +  0.2  h)  even  at  50  ttM 
although the steady state force levels could reach close to that observed with PDBu. 
Similar slow responses to PMA have also been observed with saponin-permeabilized, 
much thinner vascular smooth muscle preparations (Itoh, Kanmura, Kuriyama, and 
Sumimoto, 1986). The phorbol ester isomers, which have no activating effect on PKC 
(Castagna, Takai, Kaibuchi, Sano,  Kikkawa, and Nishizuka,  1982),  such as 4a-PDBu 
(or  4et-PMA)  produced  no  potentiating  effects  on  the  contractile  properties  at 
concentrations up to  100 ttM at either a pCa of 7 or 5 (Fig.  1 B). 
The response of the cx-toxin perrneabilized muscle to 10 I~M diC6, a synthetic DAG 
is shown in Fig.  1 C.  At pCa 7,  the contractile  force was enhanced  from 2  to 50  -+ 
2.5% of maximum with a half time of 3.6  +- 0.3 min. The ECs0 of diC6 on amplitude 
of contraction  at  pCa  7  was  1  p.M.  In  the  case of diC8,  similar  stimulation  of the 
contractile force (49 -+ 2.4%) was observed at pCa 7 over the concentration range of 
30-100 ttM. However, the half time of 7.0 -+ 0.4 min for diCs-induced contraction at 
pCa  7  was  significantly  longer  than  that  in  the  presence  of  diC6.  This  may  be 
attributable to a  slower penetration into the muscle because diC8 has a longer chain 
length.  A  slight but  significant  increase  in  force from 2  to  13%  at pCa  7 was also 
observed with  the  inactive  stereoisomer  of diCs,  1,3-dioctanoylglycerol  (100  ~M) 
(Boni and Rando,  1985),  but this is most likely due to a  small degree of contamina- 
tion by the active 1,2-isomer. 
Because  1,2-DAGs can be either phosphorylated by DAG kinase  to phosphatidic 
acid or hydrolyzed by DAG lipase,  the effect of DAG kinase  inhibitor,  R59022,  on 
these  preparations was also examined.  R59022  (50  IzM) at pCa  7  increased  steady 
state force from 2 to 35  -  3.7% of maximum force at pCa 5. An increase in Ca  2§  to 
pCa 6.7 resulted in a  much greater potentiation of contraction from 7  -  1.0% to 62 
-+  3.2% with a  half time of 8.7  -+ 0.3  min (Fig.  1 D). These results were consistent 
with the increased accumulation of DAG in smooth muscle. 
PKC  activators  also  markedly  shifted  the  Ca  2+  sensitivity  of  the  regulatory/ 
contractile apparatus in ct-toxin-permeabilized femoral artery smooth muscle (Fig. 2; 
also see Nishimura and van Breemen,  1989). The steady state pCa-force relationship 
was obtained by cumulatively increasing Ca  2§ concentrations. PDBu (3 ~M) and diC6 272  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  -  VOLUME  104  ￿9  1994 
(30 I~M) increased the Ca  2+ sensitivity (defined as a reciprocal of the concentration of 
free  Ca  2+  required  for  50%  of  maximum  contraction)  by  five-  and  threefold, 
respectively,  and evoked a  significant force (5-10% of the  maximum force in either 
case) even at pCa  > 8 (10 mM EGTA and no added calcium). At pCa 5, neither PDBu 
nor diC6 affected the maximum force (Fig.  2) for at least  60 min.  This observation 
was similar to that with GTP~/S which shifted the Ca2+-force relationship,  but did not 
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FIGURE  2.  Increase  in  Ca 2+ 
sensitivity  of  the  regulatory/ 
contractile apparatus ofet-toxin- 
permeabilized  smooth  muscle 
by 3 ~M PDBu (A) and 30 IxM 
diC6  (B)  at  pH  7.1  and  20~ 
The steady state Ca~+-force re- 
lationship  was  obtained  by cu- 
mulatively  increasing  Ca  2+  in 
the  presence  (solid  circle)  or in 
the absence (open circle) of satu- 
rating concentrations  of either 
PDBu or diC6. Force was  nor- 
malized to the force produced 
at pCa 5. Each value is mean -+ 
SE of seven experiments. 
To examine whether or not the observed Ca  2+ sensitization by PKC activators is a 
direct effect on the regulatory/contractile  apparatus  in smooth muscle,  saponin (0.2 
mg/ml)-permeabilized  smooth  muscle  preparations  were  used  because  in  phasic 
smooth muscle such preparations  exhibit normal Ca  z+ dependence but show little or 
no  receptor/G  protein-coupled  responses  (Kitazawa  et  al.,  1991b).  Addition  of a 
saturating concentration of PDBu (3 IxM) and of GTP~/S (100 IxM) at pCa 6.7 resulted 
in a  negligible  (P  >  0.1)  increase  in force from 3  -+  0.6% to 5  -  0.9%  and  to 6  -+ 
0.9%  of maximum  at  pCa  5,  respectively.  1  ~M  calmodulin  was  added  to  these 
preparations  because  the  endogenous  calmodulin  can  diffuse  out  during  and MASUO ET AL.  Ca  e+ Sensitization  by Protein Kinase C  273 
following saponin permeabilization. On  the other hand,  microcystin-LR (10  ~M), a 
direct inhibitor of protein phosphatase,  rapidly increased force at pCa6.7  to  96  + 
1.5% of maximum, indicating the presence of active MLC kinase and phosphatase in 
this preparation. This result suggests that phorbol ester-induced Ca  2+  sensitization, 
like that of GTPTS,  either requires membrane-associated and/or  soluble protein(s), 
or that vigorous permeabilization with saponin  inactivates the pathway activated by 
phorbol ester in the receptor/G protein-coupled preparations. 
The Effects of PKC Activators  and  GTPyS  on MLC  Phosphorylation 
Table  I  shows  MLC  phosphorylation  in  the  presence  and  absence  of GTP~/S  and 
various PKC activators at saturating concentrations. To measure  MLC phosphoryla- 
tion,  strips were  rapidly frozen  at  the  incubation  time  required  for  ~ 80%  of the 
maximum  potentiation of force  after  each  activator was  applied.  GTP~/S  markedly 
increased MLC phosphorylation at pCa 7  (Table I) with increased force development 
TABLE  I 
Effect of GTP~S and  Various Protein Kinase C Activators on MLC Phosphorylation in 
a-toxin  Permeabilized Rabbit Femoral Artery at 20~ 
pCa, substance, incubation time  Control  + Activators  P 
pCa 7,  100 I~M GTP,/S, 5 min 
pCa 7, 3 ~M PDBu, 5 min 
pCa 7,  100 I~M 4a-PDBu, 5 min 
pCa 7, 0.1 I~M PDBu, 25 rain 
pCa 7, 50 ~M PMA, 150 rain 
pCa 7,  10 ~M diCr, 5 rain 
pCa 6.7, 50 I~M DAGKI:, 15 rain 
Percent of total MLC •  SEM (n) 
23 •  2.6 (5)  56 •  3.4 (4)  <0.01 
23 •  2.6 (5)  49 --- 4.4 (5)  <0.01 
23 -  2.6 (5)  17 •  5.7 (4)  NS* 
15 •  2.1 (5)  31 •  1.0 (5)  <0.01 
16 •  2.0 (3)  32 •  1.5 (4)  <0.01 
23 •  2.6 (5)  35 •  4.4 (6)  <0.05 
25 •  4.6 (5)  50 •  3.4 (6)  <0.01 
*NS; not significant. :DAGKI; DAG kinase inhibitor (R59022). 
MLC  phosphorylation  was  assayed with  two-dimensional isoelectric focusing/SDS  gel  electrophoresis 
(Kitazawa et al., 1991a). Values are expressed as a percent of the total of phosphorylated plus unphosphory- 
lated MLC. PKC activators were added after 10-rain incubation in pCa 7- or pCa 6.7- containing solution. 
Unpaired t test compared MLC phosphorylation in the presence of GTP~S or PKC activators with controls. 
(Fig.  1).  All  PKC  activators  significantly  increased  MLC  phosphorylation  under 
CaZ+-clamped conditions.  PDBu  (3  I~M)  at  pCa  7  markedly increased  MLC  phos- 
phorylation to a  level similar to that induced by GTP-r  at pCa 7 (Table I) or by pCa 
6.3 alone (57  -  2.5%). 4a-PDBu at 100  I~M, which is inactive toward PKC, increased 
neither MLC  phosphorylation (Table I) nor force development.  It should be noted, 
however, that 0.1  IxM PDBu or 50  IxM PMA significantly increased MLC phosphory- 
lation, but the phosphorylation level was significantly lower than that in the presence 
of 3  I~M  PDBu  or  100  ~M  GTP~/S. As mentioned  above,  0.1  I~M  PDBu  or  50  IxM 
PMA increased force to the same steady state level as those of 3  I~M PDBu or 100 IxM 
GTP~/S, but the rate of force development with the former was much slower than that 
with the latter. 
PDBu  (3  I~M)  at pCa  7  significantly increased not  only monophosphorylation  of 
MLC (from 23  -+ 2.6% for the control to 44  -  4.2%) but also diphosphorylation from 
0  +- 0.1  to 5  -  1.9%. The total for both phosphorylations in the presence of PDBu 274  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104  ￿9  1994 
was 49  -  4.4% (Table I). However, the level of increased diphosphorylation was not 
significantly (P >  0.1) different from the values obtained at pCa 6.3 alone (4 -+  1.3%) 
or  in  the  presence  of GTPTS  at  pCa  7  (8 -  1.9%).  At  maximum  Ca  2§  (pCa  5), 
however,  PDBu  did  not  significantly  increase  either  mono-  (from  77_  4.5  to 
78 _  1.7% of total MLC)or diphosphorylation of MLC (from  13 -  2.4 to 18 -  0.9% 
of total MLC). 
To determine whether or not phorbol ester-induced increases in MLC phosphory- 
lation corresponding to force development  are  responses  unique  to ~t-toxin perme- 
aTF',S 
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FIGURE 3.  PDBu- (A) and GTP~/S-induced  (B) increase in MLC phosphorylation and force at 
constant Ca  ~+ in [3-escin-permeabilized  smooth muscle.  Femoral artery smooth muscle strips 
were permeabilized with  [~-escin as described  in the Methods and incubated in the relaxing 
solution (pCa >  8) followed by stimulation with submaximal Ca  ~+ (pCa 6.5) in the absence of 
calmodulin for 10 rain. PDBu (3 o,M) or GTPTS (100 ~M)was added in the pCa 6.5-containing 
solution.  Strips  were  last  stimulated  with  pCa  5  in  the  absence  of stimulants  to  obtain  a 
maximum force. Values inserted in the figure are the average phosphorylation (percent of total 
MLC -+ SE of 4-5 experiments) at each indicated point. 
abilized  preparations,  we  used  13-escin  permeabilized  smooth  muscle  preparations 
that also retain receptor/G protein responses (Kobayashi et al.,  1989). At 5 min after 
stimulation at pCa 6.5 in the absence of added calmodulin, PDBu (3 I~M) and GTPTS 
(100  ~.M)  significantly  (P  <  0.01)  increased  the  amount  of phosphorylated  MLC 
from  13  -  1.3% to 26  -  2.1% and to 31  +  2.3% of total MLC, respectively (Fig. 3). 
Although  levels  of  MLC  phosphorylation  under  these  conditions  were  lower  in 
13-escin  permeabilized  preparations  than  those  in  a-toxin  permeabilized  prepara- MASUO ET AL.  Ca  2+ Sensitization by Protein Kinase C  275 
tions, the percent increase in the phosphorylation by PDBu or GTP~tS as compared 
with control values was similar in both preparations. 
Analysis of the Phosphopeptides of MLC 
It is known that smooth muscle MLC can be phosphorylated at various sites in vitro 
by MLC kinase and PKC (Ikebe, Hartshorne, and Elzinga,  1986,  1987a;  Bengur et 
al.,  1987).  Phosphopeptide analyses were performed to identify the  sites  of phos- 
phorylation increased by PDBu or GTP~/S at constant Ca  2+. The et-toxin permeabi- 
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FIGURE 4.  Reverse  phase 
chromatography  of  phospho- 
peptides  of MLC. Trypsin-di- 
gested,  s2P-labeled phospho- 
peptides were  applied  to  C18 
reverse  phase  column  and 
eluted  with  CHsCN  gradients 
(--) as described in the Materi- 
als and Methods.  The radioac- 
tivity of each  fraction was  de- 
tected  by  Cerenkov  counting 
(--O---).  (A)  chromatography 
of  radioactive  fractions  from 
isolated  MLC  phosphorylated 
by turkey gizzard  MLC kinase; 
(B)  from  isolated  MLC  phos- 
phorylated  by  bovine  brain 
PKC; (C) from MLC of tx-toxin 
permeabilized  smooth  muscle 
strips activated by pCa 5 alone; 
(D)  from  MLC  of permeabi- 
lized strips activated by pCa 6.7 
alone; (E) from MLC of perme- 
abilized strips activated by pCa 
6.7 and 4  wM PDBu; (F) from 
MLC  of  permeabilized  strips 
activated  by pCa  6.7  and  100 
~M GTP~S. 
lized strips were incubated for 15 min in solutions containing 4 mM total [~/-3~P]ATP 
at various Ca  2+ concentrations under essentially the same conditions used for force 
measurements except creatine phosphate. MLC, isolated by SDS-polyacrylamide gel 
electrophoresis, was completely digested by trypsin and subjected to phosphopeptide 
analysis using C18 reverse phase column (see Materials and Methods). As a control, 
isolated MLC was phosphorylated either by MLC kinase (to 1.2 mol P/mol MLC) or 
by PKC (to 1.4 mol P/mol MLC) and also subjected to phosphopeptide analysis (Fig. 
4, A and B ). The peptides phosphorylated by MLC kinase (at Ser-19 alone or at both 276  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104  ￿9  1994 
Ser-19 and Thr-18; see Ikebe et al.,  1986) were eluted at  ~ 45-55% of CHsCN (Fig. 
4A),  while  the  peptides  containing PKC-induced phosphorylation  (Fig.  4 B) were 
eluted much earlier in the acetonitrile gradient. One was eluted in the flow-through 
fraction and the other at 2-4% CHsCN. Using the methods of Ikebe et al. (1987a), it 
was  confirmed that  the flow-through fraction of an acetonitrile gradient contained 
phosphothreonine while the fraction eluted at 2-4% acetonitrile contained phospho- 
serine as determined by phospho-amino acid analysis. Phosphorylation sites of MLC 
from permeabilized strips activated by Ca  2+  alone were the  same as those of MLC 
phosphorylated by  MLC  kinase  (Fig.  4,  C  and  D).  Neither  PDBu  (Fig.  4 E)  nor 
GTP~S (Fig. 4 F) at pCa 6.7 significantly induced phosphorylation at PKC sites, and 
only the  peptides  phosphorylated by MLC  kinase  (see  Fig.  4 A ) were  detected.  It 
should  be  noted  that  some  of the  phosphorylated  MLC  was  lost  during  the  gel 
washing  steps  and  the  total  counts  that  appeared  in  the  C18  reverse  phase 
chromatography  do  not  represent  the  original  total  s2p  incorporation.  Phospho- 
amino acid analyses of the peptides of MLC from permeabilized strips revealed that 
the predominant phosphorylation was on the serine residue although minor phos- 
phorylation (~ 10%) on the threonine site was also observed. 
The Effect of Phorbol Ester on the Time Course of MLC Phosphorylation 
and Force Development 
An increase in both MLC phosphorylation and force induced by phorbol esters may 
result from either stimulation of MLC kinase and/or inhibition of MLC phosphatase. 
In  a  previous  study  (Kitazawa  et  al.,  1991b),  adenosine  5'-[~/-thio]triphosphate 
(ATP~/S) was used as a substrate for MLC kinase to determine the effect of GTP~/S on 
the  time  course  of MLC  thiophosphorylation,  because  MLC  thiophosphorylation 
cannot be removed by MLC phosphatase (Cassidy, Hoar, and Kerrick, 1979). In the 
present study,  however, ATP~/S was  not used because PKC does  not utilize it as a 
substrate  (unpublished  observation;  Parente,  Walsh,  Kerrick,  and  Hoar,  1992). 
Instead,  microcystin-LR, a  potent and  specific phosphatase  inhibitor (MacKintosh, 
Beattie, Klumpp, Cohen, and Codd,  1990) was used to block MLC dephosphoryla- 
tion and measure the rate of MLC phosphorylation. Effect of PDBu on the rate of 
MLC  phosphorylation  was  measured  in  the  presence  of ATP  and  a  saturating 
concentration  (10  IxM) of microcystin-LR. This  phosphatase  inhibitor  rapidly  in- 
creased  force  development  maximally  in  saponin-permeabilized  arterial  smooth 
muscle  (also  see  Kitazawa  et  al.,  1991b),  but  it  did  not  affect  a  submaximally 
Ca2+-activated contraction of a-toxin-permeabilized preparations. This indicates that 
the inhibitor does not penetrate the latter preparations. Okadaic acid, another well 
known phosphatase inhibitor, is not suitable for our experiments, because although it 
is  known  that  this  inhibitor  is  membrane  permeable,  the  potentiating  effect on 
ct-toxin-permeabilized smooth muscle contraction was slow and the sensitivity to this 
inhibitor of protein phosphatase type 1, including smooth muscle MLC phosphatase 
(Gong,  Cohen,  Kitazawa,  Ikebe,  Masuo,  Somlyo, and  Somlyo,  1992a),  is  very low. 
Therefore, another receptor/G protein-coupled,  ~-escin-permeabilized preparation 
(Kobayashi et al.,  1989) permeable to relatively large molecules such as calmodulin, 
was used for rapid introduction of microcystin-LR into cells. In [3-escin-permeabilized 
smooth  muscle,  3  p~M  PDBu  and  100  o~M  GTPTS  in  the  absence  of additional MAsuo FT AL.  Ca  2+ Sensitization by Protein Kinase C  277 
calmodulin markedly increased force at pCa 6.7 from 0% to 39 -+  1.0% and to 36 -+ 
2.6%, respectively, of maximum force at pCa 5  (Fig.  3), indicating the existence of 
both  PKC-  and  G  protein-coupled  pathways  in  this  preparation.  However,  both 
potentiating effects were somewhat smaller than those found in a-toxin permeabi- 
lized preparations (Fig. 3). 
After  permeabilization with  40  o,M  13-escin, strips  were  incubated  in  the  rigor 
(ATP-free),  1  mM  EGTA-containing  solution  with  2  mM  glucose  and  29  U/ml 
hexokinase for 20 min at 20~  to deplete ATP remaining in the cells. Then, the fibers 
were  transferred  to  the  rigor  solution  containing  10  I~M  microcystin-LR with  or 
without either PDBu (3 I~M) or GTPvS (100 ~M) for 10 min. Under these conditions, 
both protein kinases and phosphatases were inactive toward MLC because both ATP 
and Ca ~+ were depleted and the phosphatases were blocked by high concentration of 
the inhibitor.  MLC phosphorylation reactions were initiated by quickly transferring 
the strips to the pCa 6.7 (buffered with  10 mM EGTA) solution containing 4.5 mM 
MgATP,  10  mM  creatine  phosphate  and  10  I~M  microcystin-LR with  or without 
PDBu or GTP~/S.  Under these conditions where kinases but not phosphatases were 
active,  the  rates  of both force development and  MLC  phosphorylation were Ca  2+ 
dependent. MLC phosphorylation at 20~  was increased by pCa 6.7 from 9  -+  1.5% 
to 22 -  3.7% of total MLC at 1 min after addition of ATP and reached to 52 -+ 2.0% 
at pCa  5,  indicating  the  presence of intact Ca2+-calmodulin-activated MLC kinase 
system in these preparations. As shown in Fig. 5, A and B, neither the rate of MLC 
phosphorylation  nor  force  development was  significantly  affected by  a  saturating 
concentration of PDBu. GTP,/S also did not influence either MLC phosphorylation 
rate  or  force  development under  conditions  inhibiting  the  dephosphorylation  in 
rabbit  tonic  (femoral  artery)  smooth  muscle.  This  confirms  the  previous  results 
(Kitazawa  et al.,  1991b)  using  phasic  smooth  muscle  (rabbit  portal vein)  that  the 
guanine nucleotides have no effect on the rate of MLC thiophosphorylation. The half 
time of force development was 2.8  -+ 0.07 min for the control, 3.0  -+ 0.12 for PDBu 
and 2.7  --- 0.11  for GTPvS. In addition, 30 I~M diC6 did not significantly (P >  0.4) 
affect the time course of force development in the presence of 10 O.M microcystin-LR. 
These results indicate that neither PKC activators nor GTPvS affect protein kinase(s) 
activity toward MLC. 
In another set of control experiments, omitting microcystin-LR from both rigor 
and ATP-containing solutions led to marked difference depending on whether PDBu 
(3 I~M) was present. Upon the addition of ATP, a large contraction was seen only in 
the  presence of PDBu.  In  another experiment,  however,  the  time course of force 
development  induced  by  addition  of microcystin-LR and  Ca  2+  (pCa  6.7)  to  the 
relaxing solution that contained ATP was not affected by the presence of 3 trM PDBu. 
These results  suggest  that  the  presence of protein phosphatase  inhibitor abolishes 
the potentiating effect of PDBu as well as GTP~,S. 
The Effect of Phorbol Ester on the Time  Course of MLC Dephosphorylation 
and Relaxation 
To examine the second possibility, i.e., the increase in MLC phosphorylation by PKC 
activation results from inhibition of MLC phosphatase, the effect of PDBu on the rate 
of dephosphorylation of MLC was measured at 20~  in a-toxin-permeabilized tonic 278  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104 ￿9 1994 
(femoral artery) smooth muscle. The fibers were first preactivated by maximum Ca  2+ 
(pCa  5)  for  10  min  and  then  the  dephosphorylation  kinetics  was  monitored  by 
incubating  the  strips  in  Ca2+-free  (10  mM  EGTA-containing)  and  ATP-free  (also 
creatine  phosphate-free)  solution  containing  100  ~M  1-(5-chloronaphthalene-l- 
sulfonyl)-lH-hexahydro-l,4-diazepine  (ML-9),  a  MLC  kinase  inhibitor  with  weak 
activity toward PKC (Saitoh, Ishikawa, Matsushima, Naka, and Hidaka,  1987). Under 
these conditions, no MLC kinase activity is expected. Thereafter, strips were rapidly 
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FIGURE 5.  Lack  of effect of 3  wM 
PDBu  and  100  I~M  GTP~/S on  the 
time course of MLC phosphorylation 
(14)  and  force  development  (B)  in 
13-escin-permeabilized  femoral artery 
smooth  muscle.  MgATP  (4.5  raM) 
plus creatine phosphate (10 raM) and 
Ca  ~+ (pCa 6.7) buffered with  10 mM 
EGTA were added to start MLC phos- 
phorylation  (A)  and  force  develop- 
ment (B)  in  the  presence of 10  v,M 
microcystin-LR,  a  potent  protein 
phosphatase inhibitor,  after a 30-rain 
incubation in the ATP-free,  Ca2+-free 
(1  mM  EGTA) rigor solution.  3  ~M 
PDBu  (triangle)  or  100  p,M  GTP~/S 
(square) with  10  wM  microcystin-LR 
was applied 10 min before ATP addi- 
tion.  All solutions  contained  100 ~M 
leupeptin and 1 mM phenylmethane- 
sulfonyl  fluoride.  Circles  represent 
control values.  Each value is mean  -+ 
SE of four to eight experiments. 
Fig.  6A  shows  the  effect  of  PDBu  and  GTP'yS  on  the  time  course  of  MLC 
dephosphorylation under the conditions where protein kinase activity toward  MLC 
was inhibited.  PDBu  (3  ~M) or GTP~/S (100  ~M) was added  to both the  activating 
solution  and  a  Ca~+-free, ATP-free  solution  containing  ML-9.  GTP~/S  significantly 
increased  the  half-time  of  MLC  dephosphorylation  from  1.2  to  2.0  min.  This 
1.72-fold increase in the half time in tonic smooth muscle is similar to the guanine 
nucleotide effect on the phasic smooth muscle, although the rate of dephosphoryla- 
tion in the absence of GTPvS was much slower in tonic than phasic smooth muscle MASUO ET AL.  Ca  2+ Sensitization by Protein Kinase C  279 
(Gong  et  al.,  1992a).  PDBu  also  significantly  increased  the  half-time  of  MLC 
dephosphorylation from control value to 2.3 min (Fig.  6 A ). This  1.96-fold increase 
was similar to that of GTP~/S. 
The effects of 3  I~M PDBu and  100  I~M GTP'yS on the relaxation rate were also 
determined under the  same conditions as those for measurement of MLC dephos- 
phorylation,  except  that  all  solutions  contained  ATP.  As  shown  in  Fig.  6 B,  the 
relaxation was much slower in the presence of GTP'yS or PDBu than in the absence of 
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FIGURE 6.  Time  courses  of 
MLC  dephosphorylation  (A) 
and  relaxation  (B)  in  ct-toxin- 
permeabilized  smooth  muscle 
with  and  without  PDBu  and 
GTP~/S.  Permeabilized  strips 
preactivated  by maximum Ca  ~+ 
(pCa  5) for  10 min were  incu- 
bated  in  a  Ca2+-free (10  mM 
EGTA) and  ATP-free  solution 
containing  100  ~M  ML-9  to 
block the protein kinase activity 
toward  MLC. 3 o,M PDBu (tr/- 
angle)  or  100  IxM  GTP~,S 
(square)  was present in both ac- 
tivating solution and Ca2+-free, 
ATP-free  solution.  Circles rep- 
resent  control  values.  Each 
value  is  mean  -+  SE of five to 
eight experiments. 
either agent. This result supports the notion that these agents act by inhibiting the 
rate  of MLC  dephosphorylation.  The  half  time  of relaxation  was  prolonged  by 
GTP~/S from 2.5  -+ 0.2 to 5.3  -- 0.2 rain. This 2.12-fold increase in the half time of 
relaxation  in  tonic  smooth  muscle  is  similar  to  that  (2.13-fold  increase)  of phasic 
smooth muscle as described previously (Kitazawa et al.,  1991b)  and also similar to the 
increase  in  the  half time  of MLC  dephosphorylation by  the  guanine  nucleotide 
analog. On the other hand, PDBu markedly (3.96-fold) increased the half-time of the 280  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104  ￿9  1994 
relaxation to 9.9  -+  0.5  min.  Relaxation in the presence of PDBu was  significantly 
slower than  in  the  presence of GTP~/S  although  the  inhibitory effect of the  same 
concentration  of phorbol  ester  on  MLC  dephosphorylation  was  not  significantly 
different from that of the guanine nucleotide analog (Fig. 6A).  In addition,  10-30 
p,M  diC6 also  significantly increased  the  half time of relaxation to 6.2  -+  0.2  min, 
which was significantly (P <  0.05) longer than that of GTP,/S. 
DISCUSSION 
The present study clearly demonstrates that agents known to activate PKC, but not 
their inactive isomers,  increase both  MLC phosphorylation at  MLC kinase-specific 
site and force development at constant Ca  z+ due to inhibition of MLC dephosphory- 
lation  rather  than  stimulation  of MLC  phosphorylation.  The  inhibition  of MLC 
phosphatase  activity would  increase  MLC  kinase/phosphatase  activity  ratio which 
results in the sensitization of MLC phosphorylation and force development to Ca  2+. 
This conclusion is supported by the results of phospho-peptide and phospho-amino 
acid  analyses  that  revealed  the  main  phosphorylation  site  to  be  Ser-19  (MLC 
kinase-specific site) during Ca  2+  sensitization by phorbol ester. At least in part, the 
inhibition of protein phosphatase may be the mechanism of synergistic interaction of 
PKC activation and Ca  2+ mobilization in smooth muscle (Park and Rasmussen,  1985) 
and perhaps, in other cell systems (Nishizuka,  1986; Berridge,  1987). 
It has been shown in phasic vascular (Kitazawa et al.,  1991b) and tracheal (Kubota 
et al.,  1992) smooth muscle, that GTP~/S, an activator of G  proteins, increases MLC 
phosphorylation  associated  with  increased  force  through  the  inhibition  of MLC 
phosphatase.  This was  confirmed in  tonic vascular  smooth  muscle  in  the  present 
study. These results further suggest that  the  inhibition of MLC  phosphatase  by G 
protein is  mediated through the  activation of PKC by DAG formed by G  protein- 
coupled  phospholipases  (Berridge,  1987;  Nishizuka,  1984;  Takuwa,  Takuwa,  and 
Rasmussen,  1986). This is further supported by the fact that inositol trisphosphate 
and its metabolites have no effect on the Ca  2+  sensitization (Kitazawa and Somlyo, 
1991).  However, GTP,/S-induced Ca  2+  sensitization may be complex and there are 
several  possibilities  that  the  Ca  2+  sensitization  might  be  mediated  by  multiple 
pathways.  For  examples,  in  phasic  smooth  muscle,  GTP,/S  further  potentiates 
contraction even in the presence of saturated concentrations of PDBu (Kitazawa and 
Somlyo,  1991),  suggesting that GTP,/S induces a  more complex cascade than does 
PKC. Alternatively, PDBu may cause incomplete activation of PKC isoforms in phasic 
smooth  muscle.  Recently,  it was  demonstrated  that  arachidonic  acid  directly,  not 
through PKC activation, inhibits MLC phosphatase and slowly  increases contractile 
Ca  2+  sensitivity  (Gong,  Fuglsang,  Alessi,  Kobayashi,  Cohen,  Somlyo,  and  Somlyo, 
1992b).  Small  G  protein,  rho  p21  might  be  involved  in  GTP~/S-induced  Ca 2+ 
sensitization  in  smooth muscle  as well  (Hirata,  Kikuchi,  Sasaki,  Kuroda,  Kaibuchi, 
Matsumura,  Seki,  Saida,  and  Takai,  1992).  It  should  also  be  mentioned  that, 
relaxation in the presence of PDBu or diC6 with inhibited MLC kinase activity was 
more  delayed than  that  expected in  the  presence of GTP~/S  (Fig.  6 B).  Although 
relaxation is not simply determined by the rate of MLC dephosphorylation (Chatter- 
jee and  Murphy,  1983;  Kuhn, Tewes, Gagelmann, Guth, Arner, and  Ruegg,  1990), 
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of dephosphorylated  MLC.  Thus,  the  physiological significance of PKC  activation 
remains obscure. 
Specific  phosphorylation  of  MLC  (Ser-19)  by  the  Ca2+/calmodulin-dependent 
MLC  kinase  is  thought  to be a  primary mechanism of smooth muscle  contraction 
(Hartshorne,  1987  and  Kamm and  Stull,  1989).  In addition,  PKC can also directly 
phosphorylate  MLC  at  residues  (Ser-1  and  -2  and  Thr-9)  distinct  from  MLC 
kinase-sites in vitro. As a result, however, actin-activated myosin ATPase is inhibited 
(Ikebe et al., 1987a; Bengur et al., 1987). Furthermore, in skinned preparations, PKC 
activators have  no  contractile effects (this  study)  and  phosphorylation of MLC  by 
purified  or  constitutively active  PKC  does  not  activate  contraction  and  does  not 
potentiate  Ca2+-activated  contraction  (Inagaki  et  al.,  1987;  Sutton  and  Haeberle, 
1990;  Parente et al.,  1992).  We observed,  however, a  significant increase  in  MLC 
phosphorylation associated with increased force by PKC activators in the receptor/G 
protein-coupled permeabilized preparations. This force/phosphorylation ratio in the 
presence of 3 ~M PDBu (Fig. 1 and Table I) was not significantly different from those 
in  the  presence  of GTP~/S  (at  pCa  7)  or  Ca 2+  (pCa  6.3)  alone.  In  fact,  a  major 
phosphorylation site of MLC in permeabilized preparations activated by PDBu or by 
GTP,/S (see also Kubota et al.,  1992) was localized at the same MLC kinase-specific 
site  as  that  activated  by  Ca  2+  alone  (Fig.  4).  These  findings  suggest  that  PKC 
activators lead to an increase in MLC phosphorylation, albeit indirectly, at the MLC 
kinase-sites  without  an  increase  in  cytoplasmic  Ca  2+.  This  is  consistent  with  the 
observation that PKC activators inhibit MLC phosphatase. However, the mechanism 
by  which  PKC  inhibits  MLC  phosphatase  remains  to  be  clarified.  Similar  Ca  2+ 
sensitizing effects of PKC activators have been observed on secretory cells (Knight, 
von  Grafenstein,  and  Athayde,  1989),  suggesting  that  the  inhibition  of protein 
phosphatase  by PKC  is  a  more general mechanism  rather than specific to smooth 
muscle.  Likewise,  PKC  may regulate  the  phosphorylation/dephosphorylation reac- 
tion of other protein kinase systems that are active under these conditions. 
Activated PKC phosphorylates purified MLC up  to three mol of P/tool of MLC 
(Bengur et al.,  1987;  Ikebe  et al.,  1987a).  Less than  2  tool of P/tool of MLC  are 
phosphorylated for in situ MLC in glycerinated smooth muscle by PKC (Sutton and 
Haeberle,  1990).  In the present a-toxin permeabilized preparations, however, PKC 
activators in  the  presence of a  protein phosphatase  inhibitor did  not  significantly 
increase the rate of MLC phosphorylation and force development (Fig. 5). Further- 
more, under conditions where MLC kinase was almost fully activated at pCa 5,  the 
presence  of  PDBu  tended  to,  but  did  not  significantly,  increase  the  ratio  of 
di-phosphorylation (from 13  to  18% of total MLC). This diphosphorylation can be 
mainly  caused  by  the  phosphorylation  at  Thr-18  (~ 10%  in  phospho-amino  acid 
analysis), but not at PKC~  sites. Phorbol ester causes only a  small increase in 
phosphorylation of PKC-sites of MLC in intact smooth muscle  (Singer et al.,  1989; 
Kamm  et al.,  1989;  Barany  et  al.,  1990,  1992;  Sutton  and  Haeberle,  1990).  The 
phosphopeptides containing PKC-specific phosphorylation sites of MLC during Ca 2+ 
sensitization by PDBu were not detectable in our phosphopeptide analysis (Fig. 4). 
This  implies  that  PKC-induced  phosphorylation  of MLC  at  PKC-specific  sites  is 
minimal or nonexistent. These results indicate that the PKC-sites of MLC may be well 282  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  104 ￿9 1994 
protected  from  phosphorylation  by  in  situ-PKC,  presumably  due  to  the  specific 
localization of the kinase in intact,  13-escin- or a-toxin-permeabilized preparations. 
In  some  types  of intact  vascular  smooth  muscle,  phorbol  esters  induce  a  large 
contraction  associated with an increase in both cytoplasmic Ca  2+  and phosphoryla- 
tion  of  MLC  (Remhold  and  Murphy,  1988;  Sato,  Hori,  Ozaki,  Takanoohmura, 
Tsuchiya,  Sugi,  and  Karaki,  1992;  Barany  et  al.,  1992).  Their  analysis  of  the 
relationship  between  Ca  2+  and  force  development  or  between  Ca  2§  and  MLC 
phosphorylation  indicated  that  Ca  2+  sensitivity  of  force  development  and  MLC 
phosphorylation  during  phorbol  ester-induced  contraction  was  similar  to  those 
during  agonist-induced  stimulation but higher  than  those  during  high  K+-induced 
stimulation.  In  permeabilized  smooth  muscle,  phorbol  esters  have been  shown  to 
increase Ca  2+ sensitivity of force development (Itoh et al.,  1988;  Nishimura and van 
Breemen,  1989) as well as MLC phosphorylation (Fujiwara et al.,  1988;  the present 
study). This type of Ca  ~+ sensitization by phorbol esters can be well explained by the 
inhibition  of MLC phosphatase by PKC activators. In some types of intact vascular 
smooth muscle, however, only small or insignificant elevation of Ca  2+ and/or  MLC 
phosphorylation was observed during  phorbol ester-induced  contraction  (Park and 
Rasmussen,  1986;  Jiang  and  Morgan,  1987,  1989;  Kamm  et  al.,  1989;  Singer, 
1990a, b;  Barany et al.,  1990;  Sato et al.,  1992).  In skinned preparations, high force 
development by phorbol ester was associated with low MLC phosphorylation (Chat- 
terjee  and  Tejada,  1986),  suggesting  MLC  phosphorylation-independent  contrac- 
tion.  This  type  of Ca  2+  sensitization  by phorbol  ester  might  be  correlated  to  the 
observation that phorbol ester markedly maintained a high force level with minimal 
MLC phosphorylation (Fig. 6). 
In summary, at constant  Ca  2+,  PKC activators enhance  MLC phosphorylation at 
MLC kinase-specific, but not PKC-specific, sites. This Ca  e+ sensitization is mainly due 
to  indirect  inhibition  of  MLC  dephosphorylation,  similar  to  that  of  G  protein- 
mediated Ca  2+ sensitization. 
We are grateful to Drs. Morris Burke, Angela Otero, Gabor Szabo, and Mortimer Lorber for helpful 
suggestions in the preparation of this manuscript. 
This work was supported by grants from the American Heart Association Virginia Affiliate, and NIH 
HL 51824 to T. Kitazawa, and NIH A.R. 41653, HL 37117, HL 47530 and the American Heart 
Association to M. lkebe. M. Ikebe is a recipient of an Established Investigatorship of the American 
Heart Association. M. Masko is a recipient of a fellowship from the ICI-Pharma Ltd., Japan. 
Original version received 2June 1993 and accepted version received 14 December 1993. 
REFERENCES 
Barany, K., E. Polyak, and M. Barany. 1992. Protein phosphorylation in arterial muscle contracted by 
high  concentration  of phorbol  dibutyrate  in  the  presence  and  absence  of Ca  2+.  Biochimica et 
Biophysica Acta. 1134:233-241. 
Barany, K., A. Rokolya, and M.  Barany. 1990. Analysis of myosin light chain phosphopeptides  in 
phorbol dibutyrate-contracted artery. Biochimica et Biophysica Acta.  1035:105-108. 
Bengur,  A.  B.,  E.  A.  Robinson,  E.  Appella,  and  J.  R.  Sellers.  1987. Sequence of  the  sites 
phosphorylated by protein kinase C in the smooth muscle myosin light chain. Journal of Biological 
Chemist~. 262:7613-7617. MASUO ET AL.  Ca  2+ Sensitization by Protein Kinase C  283 
Berridge, M.J.  1987.  Inositol trisphosphate  and diacylglycerol: two interacting second messengers. 
Annual Review of Biochemistry. 56:159-193. 
Boni, L. T., and R. R. Rando.  1985.  The nature of protein kinase C activation by physically defined 
phospholipid vesicles and diacylglycerols.  Journal of Biological Chemistry. 260:1081 9-10825. 
Cassidy, P., P. E. Hoar, and W. G. L, Kerrick. 1979.  Irreversible thiophosphorylation and activation of 
tension in functionally skinned  rabbit  ileum strips by  [sSS]ATP3,S. Journal  of Biological Chemistry. 
254:11148--11153. 
Castagna,  M., Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa,  and Y. Nishizuka.  1982.  Direct activation 
of calcium-activated, phospholipid-dependent  protein kinase by tumor-promoting phorbol esters. 
Journal of Biological Chemistry. 257:7847-7851. 
Chatterjee,  M.,  and  R.  A.  Murphy.  1983.  Calcium-dependent  stress  maintenance  without  myosin 
phosphorylation in skinned smooth muscle. Science. 221:464--466. 
Chatterjee,  M.,  and  M.  Tejada.  1986.  Phorbol  ester-induced  contraction  in  chemically  skinned 
vascular smooth muscle. American  Journal of Physiology. 251 :C356-C361. 
de Chaffoy de Courcelles, D.,  P. Roevens, and H. Van Belle. 1985.  R 59022,  a diacylglycerol kinase 
inhibitor:  Its  effect  on  diacylglycerol and  thrombin-induced  C  kinase  activation  in  the  intact 
platelet. Journal of Biological Chemistry. 260:15762-15770. 
Fujiwara,  T.,  T.  Itoh,  Y.  Kubota,  and  H.  Kuriyama.  1988.  Actions of a  phorbol  ester  on  factors 
regulating contraction in rabbit mesenteric artery. Circulation Research. 63:893-902. 
Fujiwara, T., T. ltoh, Y. Kubota, and H. Kuriyama. 1989.  Effects of guanosine nucleotides on skinned 
smooth muscle tissue of rabbit mesenteric artery.Journal  of Physiology. 408:535-547. 
Gong, M. C.,  P. Cohen, T. Kitazawa,  M. Ikebe, M. Masuo, A. P. Somlyo, and A. V. Somlyo. 1992a. 
Myosin light chain phosphatase  activities and  the effects of phosphatase  inhibitors  in tonic and 
phasic smooth muscle. Journal of Biological Chemistry. 267:14662-14668. 
Gong, M. C., A. Fuglsang, D. Alessi, S. Kobayashi, P. Cohen, A. V. Somlyo, and A. P. Somlyo. 1992b. 
Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. 
Journal of Biolog~al Chemistry. 267:21492-21498. 
Hartshorne,  D.J.  1987.  Biochemistry of the contractile process in smooth muscle. In Physiology of 
the Gastrointestinal Tract. L. R. Johnson, editor. Raven Press,  New York. 423--482. 
Hirata,  K., A.  Kikuchi, T. Sasaki,  S.  Kuroda,  K.  Kaibuchi, Y.  Matsuura,  H.  Seki,  K.  Saida,  and Y. 
Takai.  1992.  Involvement of rho p21  in the GTP-Enhanced  Calcium Ion Sensitivity of Smooth 
Muscle Contraction.Journal of Biological Chemistry. 267:8719-8722. 
Horiuti, K. 1988.  Mechanism of contracture on cooling of caffeine-treated frog skeletal muscle fibres. 
Journal of Physiology. (London).  398:131-148. 
Ikebe, M., and D.J. Hartshorne.  1985.  Phosphorylation of smooth muscle myosin at two distinct sites 
by myosin light chain kinase. Journal of Biological Chemistry. 260:10027-10031. 
Ikebe,  M.,  D. J.  Hartshorne,  and  M.  Elzinga,  1986.  Identification,  phosphorylation,  and  dephos- 
phorylation  of a  second  site for myosin light chain  kinase  on  the  20,000-dahon  light chain  of 
smooth muscle myosin. Journal of Biological Chemistry. 261:36--39. 
Ikebe,  M.,  and  S.  Reardon.  1990.  Phosphorylation of bovine platelet myosin by protein  kinase C. 
Biochemistry. 29:2713-2720. 
Ikebe, M., D.J. Hartshorne, and M. Elzinga. 1987a.  Phosphorylation of the 20,000-dalton light chain 
of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase.Journal 
of Biological Chemistry. 262:9569-9573. 
Ikebe,  M.,  M.  Stepinska,  B.  E.  Kemp, A.  R.  Means,  and  D. J.  Hartshorne.  1987b. Proteolysis of 
smooth  muscle  myosin  light  chain  kinase.  Formation  of inactive  and  calmodulin-independent 
fragments. Journal of Biological Chemistry. 260:13828-13834. 284  THE JOURNAL OF  GENERAL PHYSIOLOGY ￿9 VOLUME 104  ￿9 1994 
Inagaki, M., H. Yokokura, T. Itoh, Y. Kanmura,  H. Kuriyama, and H. Hidaka.  1987.  Purified rabbit 
brain protein kinase C  relaxes skinned vascular smooth muscle and phosphorylates  myosin light 
chain. Archives of Biochemistry and Biophysics. 254:136-141. 
Itoh, T., Y. Kanmura, H. Kuriyama, and K. Sumimoto. 1986. A phorbol ester has dual actions on the 
mechanical response in the rabbit mesenteric and porcine coronary arteries. Journal of Physiology. 
375:515-534. 
ltoh, T., Y. Kubota, and H. Kuriyama.  1988.  Effects ofa phorbol ester on acetylcholine-induced Ca  2+ 
mobilization and contraction in the porcine coronary artery.Journal of Physiology. 397:401-419. 
Jiang,  M.  J.,  and  K.  G.  Morgan.  1987.  Intracellular  calcium  levels  in  phorboi  ester-induced 
contractions of vascular muscle. American  Journal of Physiology. 253:H 1365-H 1371. 
Jiang,  M. J.,  and  K.  G.  Morgan.  1989.  Agonist-specific myosin phosphorylation  and  intracellular 
calcium during isometric contractions of arterial smooth muscle. Pflfiger Archiv. 413:637-643. 
Kamm, K. E.,  L. Hsu, Y. Kubota,  and J. T. Stull.  1989.  Phosphorylation of smooth muscle myosin 
heavy and light chains: effects of phorbol dibutyrate and agonists. Journal of Biological Chemistry. 
264:21223-21229. 
Kamm,  K.  E.,  and J. T.  Stull.  1989.  Regulation of smooth muscle contractile elements by second 
messengers. Annual Review of Physiology. 51:299-313. 
Kitazawa,  T.,  S.  Kobayashi,  K.  Horiuti, A. V.  Somlyo, and A. P.  Somlyo.  1989.  Receptor-coupled, 
permeabilized smooth muscle: role of the phosphatidylinositol cascade, G-proteins, and modula- 
tion of the contractile response to Ca~+.Journal of Biological Chemistry. 264:5339-5342. 
Kitazawa,  T.,  B.  D.  Gaylinn,  G.  H.  Denney,  and  A.  P.  Somlyo.  1991a.  G-protein-mediated 
Ca~+-sensitization  of smooth  muscle  contraction  through  myosin  light  chain  phosphorylation. 
Journal of Biological Cheraistvy. 266:1708-1715. 
Kitazawa,  T.,  M.  Masuo,  and A.  P.  Somlyo.  1991b. G  protein-mediated  inhibition of myosin light 
chain phosphatase  in vascular smooth muscle. Proceedings of the National Academy of Sciences, USA. 
88:9307-9310. 
Kitazawa,  T.,  S. Reardon,  M.  Ikebe, and  M.  Masuo.  1993.  Mechanism of Ca  ~+  sensitizing effect of 
protein kinase C on smooth muscle. Biophysical  Journal. 64:A121. (Abstr.) 
Kitazawa,  T.,  and A. P.  Somlyo.  1990.  Desensitization and  muscarinic resensitization of force and 
myosin  light  chain  phosphorylation  to  cytoplasmic  Ca  ~+  in  smooth  muscle.  Biochemical and 
Biophysical Research Communications. 172:1291-1297. 
Kitazawa, T., and A. P. Somlyo. 1991.  Modulation of Ca  ~+ sensitivity  by agonists in smooth muscle. In 
Regulation of Smooth  Muscle Contraction.  R.  Moreland,  editor.  Plenum  Publishing Corp.,  New 
York. 97-109. 
Knight,  D.  E.,  H.  yon  Grafenstein,  and  C.  M.  Athayde.  1989.  Calcium-dependent  and  calcium- 
independent exocytosis. Trends in Neuroscwnces. 12:451-458. 
Kobayashi,  S.,  T.  Kitazawa,  A.  V.  Somlyo,  and  A.  P.  Somlyo.  1989.  Cytosolic  heparin  inhibits 
muscarinic  and  alpha-adrenergic  Ca  ~+  release in  smooth muscle. Journal of Biological Chemistry. 
264:17997-18004. 
Kubota,  Y.,  M.  Nomura,  K.  E.  Kamm,  M.  C.  Mumby,  and J.  T.  Stull.  1992.  GTP~/S-dependent 
regulation of smooth muscle contractile elements. American  Journal of Physiology. 262:C405-C410. 
Kuhn,  H.,  A.  Tewes,  M.  Gagelmann,  K.  Guth,  A.  Arner,  and  J.  C.  Ruegg.  1990.  Temporal 
relationship  between force, ATPase activity,  and  myosin phosphorylation  during a  contraction/ 
relaxation cycle in a skinned smooth muscle. Pflfigers Archiv. 416:512-518. 
Lapetina,  E.  G.,  B.  Reep,  B.  R.  Ganong,  and  R.  M.  Bell.  1985.  Exogenous sn-l,2-diacylglycerols 
containing saturated fatty acids function as bioregulators of protein kinase C in human  platelets. 
Journal of Biological Chemistry. 260:1358-1361. MASUO ET AL.  Ca  2+ Sensitization by Protein Kinase C  285 
MacKintosh,  C.,  K.  A.  Beattie,  S.  Klumpp,  P.  Cohen,  and  G.  A.  Codd.  1990.  Cyanobacterial 
microcystin-LR is  a  potent  and  specific inhibitor of protein  phosphatase  1 and  2A from both 
mammals and higher plants. FEBS Letters. 264:187-192. 
Miller, J. R., D.J. Hawkins, andJ. N. Wells.  1986.  Phorbol diesters alter the contractile responses of 
porcine coronary artery.Journal of Pharmacology and Experimental Therapeutics. 239:38-42. 
Morgan, J. P.,  and  K. G. Morgan.  1984.  Stimulus-specific patterns  of intracellular calcium levels in 
smooth muscles of ferret portal vein. Journal of Physiology. 351:155-167. 
Nishikawa,  M.,  H.  Hidaka,  and  R.  S.  Adelstein.  1983.  Phosphorylation  of smooth  muscle  heavy 
meromyosin by  calcium-activated,  phospholipid-dependent  protein  kinase:  the  effect on  actin- 
activated MgATPase activity.Journal of Biological Chemistry. 258:14069-14072. 
Nishimura,  J.,  M.  Kobler,  and  C.  van  Breemen.  1988.  Norepinephrine  and  GTP~/S  increase 
myofilament  Ca  2+  sensitivity  in  a-toxin  permeabilized  arterial  smooth  muscle.  Biochemical and 
Biophysical Research Communication. 157:677-683. 
Nishimura, J., and C. van Breemen. 1989.  Direct regulation of smooth muscle contractile elements by 
second messengers. Biochemical and Biophysical Research Communications. 163:929-935. 
Nishizuka, Y.  1984.  Turnover of inositol phospholipids and signal transduction.  Science. 225:1365- 
1370. 
Nishizuka, Y.  1986.  Studies and perspectives of protein kinase C. Science. 233:305-312. 
Ozaki, H., T. Ohyama, T. Sato, and H. Karaki.  1990.  Ca2+-dependent and independent mechanisms 
of sustained contraction in vascular smooth muscle of rat aorta. Japanese Journal of Pharmacology. 
52:509-512. 
Parente, J. E., M. P. Waish, W. G. L. Kerrick, and P. E. Hoar.  1992.  Effects of the constitutively active 
proteolytic fragment of protein kinase C on the contractile properties of demembranated  smooth 
muscle fibers.Journal  of Muscle Research and Cell Motility. 13:90--99. 
Park,  S.,  and  H.  Rasmussen.  1985.  Activation of tracheal  smooth  muscle  contraction:  synergism 
between Ca  ~+ and activators of protein kinase C. Proceedings of National Academy of Sciences, USA. 
82:8835-8839. 
Park,  S.,  and  H.  Rasmussen.  1986.  Carbachol-induced  protein  phosphorylation  changes  in bovine 
tracheal smooth muscle. Journal of Biological Chemistry. 261:15734-15739. 
Rasmussen,  H., J.  Forder,  I.  Kojima, and A.  Scriabine.  1984.  TPA-induced contraction of isolated 
rabbit vascular smooth muscle. Biochemical Biophysical Research Communications. 122:776-784. 
Rasmussen,  H., Y. Takuwa, and S. Park.  1987.  Protein kinase C in the regulation of smooth muscle 
contraction. FASEB Journal.  1  : 177-185. 
Rembold,  C.  M.,  and  R.  A.  Murphy.  1988.  [Ca2+]-dependent  myosin phosphorylation  in phorbol 
diester stimulated smooth muscle contraction. American  Journal of Physiology. 255:C719--C723. 
Ruzycky, A. L., and K. G. Morgan.  1989.  Involvement of the protein kinase C system in calcium-force 
relationships in ferret aorta. British  Journal of Pharmacology. 97:391-400. 
Sato, K., M. Hori, H. Ozaki, H. Takanoohmuro, T. Tsuchiya, H. Sugi, and H. Karaki.  1992.  Myosin 
phosphorylation-independent  contraction  induced  by phorbol  ester  in vascular smooth  muscle. 
Journal of Pharmacology and Experimental Therapeutics. 261:497-505. 
Saitoh,  M.,  T.  Ishikawa,  S.  Matsushima,  M.  Naka,  and  H.  Hidaka.  1987.  Selective inhibition  of 
catalytic  activity  of  smooth  muscle  myosin  light  chain  kinase. Journal  of Biological Chemistry. 
262:7796-7801. 
Singer,  H.  A.  1990a.  Protein  kinase  C  activation  and  myosin  light  chain  phosphorylation  in 
32P-labeled  arterial smooth muscle. American  Journal of Physiology. 259:C631-C639. 
Singer, H. A.  1990b. Phorbol ester-induced stress and myosin light chain phosphorylation  in swine 
carotid  medial  smooth muscle. Journal  of Pharmacology and Experimental Therapeutics. 252:1068- 
1074. 286  THE JOURNAL OF  GENERAL PHYSIOLOGY ￿9 VOLUME 104 ￿9 1994 
Singer,  H.  A.,  J.  w.  Oren,  and  H.  A.  Benscoter.  1989.  Myosin  light  chain  phosphorylation  in 
s~P-labeled  rabbit aorta  stimulated  by  phorbol  12,13-dibutyrate  and  phenylephrine. Journal of 
Biological Chemistry. 264:21215-21222. 
Sutton, T. A.,  and J. R.  Haeberle.  1990.  Phosphorylation by protein kinase C  of the 20,000-dalton 
light chain of myosin in intact and chemically skinned vascular smooth muscle.Journal of Biological 
Chemistry. 265:2749--2754. 
Takuwa,  T.,  N.  Takuwa,  and  H.  Rasmussen.  1986.  Carbachol  induces  a  rapid  and  sustained 
hydrolysis of polyphosphoinositide in bovine tracheal smooth muscle measurements of the mass of 
polyphosphoinositides,  1,2-diacylglycerol,  and  phosphatidic acid. Journal  of Biological Chemistry. 
261:14670-14675. 